NCT06721897 Effectiveness of a Prehabilitation Program for Hip or Knee Arthroplasty Surgery.
| NCT ID | NCT06721897 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Jaén |
| Condition | Prehabilitation |
| Study Type | INTERVENTIONAL |
| Enrollment | 44 participants |
| Start Date | 2025-05-15 |
| Primary Completion | 2026-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 44 participants in total. It began in 2025-05-15 with a primary completion date of 2026-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
We live in an increasingly aging society in which the incidence of osteoarticular diseases increases, among which osteoarthritis (OA) stands out. OA is a degenerative disorder of the different components of the joint leading to a progressive destruction of the same. The hip and knee being the most affected joints, OA presents multiple symptoms such as pain, stiffness and functional limitation, also causing psychological disorders such as anxiety, depression, quality of sleep and poor perception of quality of life. Conventional treatment is aimed at alleviating symptoms, but when conservative therapies fail in the more advanced stages of the disease, total joint replacement surgery or arthroplasty is the therapeutic option of choice. Strength physical exercise (PE) and aerobic training have been shown to be effective in OA, obtaining positive effects on the symptoms and on variables that deteriorate this disease. The concept of pre-habilitation or preoperative rehabilitation has been shown through other studies in different pathologies (cardiopulmonary and musculoskeletal) to have positive effects at a clinical and functional level, however, the planning of a pre-habilitation protocol in hip or knee arthroplasty is still controversial. The purpose of this study is to determine the effect that a prehabilitation program will produce and its possible usefulness in those subjects who are waiting for a hip or knee arthroplasty. It is expected to find favorable results that support this therapy when it comes to reducing postoperative recovery times, functional capacity and other psychological variables of interest. This powerful tool could represent a non-pharmacological and non-invasive therapy, as well as being useful and economical in the management of patients with OA in advanced stages.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of hip OA stage I-III of the Tönnis classification or diagnosis of knee OA stage I-IV of the Ahlbäck classification * Patients requiring hip/knee arthroplasty surgery * Signed informed consent * Obtaining a score equal to or greater than 8 repetitions in the Sit to Stand test * Patients with the ability to walk without technical aids or in need of some help (up to two canes or a walker) Exclusion Criteria: * Cognitive deficit/Dementia states * Cancer processes * Associated vascular and inflammatory pathologies * Associated neurological pathologies * Contraindications to physical exercise
Contact & Investigator
IRENE MARIA IMLP LOPERA PAREJA, PRINCIPAL INVESTIGATOR
PRINCIPAL INVESTIGATOR
University of Jaen
Frequently Asked Questions
Who can join the NCT06721897 clinical trial?
This trial is open to participants of all sexes, aged 45 Years or older, up to 80 Years, studying Prehabilitation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06721897 currently recruiting?
Yes, NCT06721897 is actively recruiting participants. Contact the research team at ireneloperapareja@gmail.com for enrollment information.
Where is the NCT06721897 trial being conducted?
This trial is being conducted at Granada, Spain.
Who is sponsoring the NCT06721897 clinical trial?
NCT06721897 is sponsored by University of Jaén. The principal investigator is IRENE MARIA IMLP LOPERA PAREJA, PRINCIPAL INVESTIGATOR at University of Jaen. The trial plans to enroll 44 participants.